J
James B. Young
Researcher at Cleveland Clinic
Publications - 538
Citations - 46895
James B. Young is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Heart failure & Transplantation. The author has an hindex of 102, co-authored 517 publications receiving 43826 citations. Previous affiliations of James B. Young include Case Western Reserve University & Baylor University.
Papers
More filters
Journal ArticleDOI
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.
Daniel E. Forman,Javed Butler,Yongfei Wang,William T. Abraham,Christopher M. O'Connor,Stephen S. Gottlieb,Evan Loh,Barry M. Massie,Barry M. Massie,Michael W. Rich,Lynne W. Stevenson,James B. Young,Harlan M. Krumholz +12 more
TL;DR: Worsening renal function occurs frequently among hospitalized HF patients and is associated with significantly worse outcomes and clinical characteristics available at hospital admission can be used to identify patients at increased risk for developing WRF.
Journal ArticleDOI
Sixth INTERMACS annual report: a 10,000-patient database.
James K. Kirklin,David C. Naftel,Francis D. Pagani,Robert L. Kormos,Lynne W. Stevenson,Elizabeth D. Blume,Marissa A. Miller,J.T. Baldwin,James B. Young +8 more
TL;DR: A comparison of two eras of continuous-flow durable devices in the USA in terms of device strategy, patient profiles, adverse event burden, survival and quality of life is featured.
Journal ArticleDOI
Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.
James K. Kirklin,David C. Naftel,Robert L. Kormos,Lynne W. Stevenson,Francis D. Pagani,Marissa A. Miller,J.T. Baldwin,James B. Young +7 more
TL;DR: The 5th annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 6 years of patient and data collection.
Journal ArticleDOI
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors.
Milton Packer,Milton Packer,Mihai Gheorghiade,James B. Young,Peter J. Costantini,Kirkwood F. Adams,Robert J. Cody,L. Kent Smith,Lucy Van Voorhees,Lynn A. Gourley,M. King Jolly +10 more
TL;DR: Patients with New York Heart Association class II or III heart failure and left ventricular ejection fractions of 35 percent or less in normal sinus rhythm who were clinically stable while receiving digoxin, diuretics, and an angiotensin-converting-enzyme inhibitor were studied.
Journal ArticleDOI
High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults Evidence From Intravascular Ultrasound
E. Murat Tuzcu,Samir R. Kapadia,Eralp Tutar,Khaled M. Ziada,Robert E. Hobbs,Patrick M. McCarthy,James B. Young,Steven E. Nissen +7 more
TL;DR: This study demonstrates that coronary atherosclerosis begins at a young age and that lesions are present in 1 of 6 teenagers, and suggest the need for intensive efforts at coronary disease prevention in young adults.